Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Femoral and sciatic nerve block versus local anesthesia plus dexmedetomidine sedation for endovascular treatment of chronic limb-threatening ischemia
PACTR202511788882617Not yet recruiting
- Sponsor
- Manar Ahmed Mahmoud
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of dexmedetomidine in chronic limb-threatening ischemia (CLTI) and pain (2 arms), sponsored by Manar Ahmed Mahmoud. Primary endpoint: Maximum intraoperative pain score. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
chronic limb-threatening ischemia (CLTI)pain
Beyond the preview
Go deeper on PACTR202511788882617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202511788882617.